Publication

Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease

American Journal of Physiology-Renal Physiology 321(2):F149-F161, 2021

Østergaard MV, Secher T, Christensen M, Salinas CG, Roostalu U, Skytte JL, Rune I, Hansen HH, Jelsing J, Vrang N, Fink LN

Subjects
3D imagingdb/db mouseTherapeutic AreaAdeno-associated virus (AAV)-mediated gene deliveryReninAAV UNx db/db mouseTargetMouseChronic kidney diseaseCompoundMethod/EndpointSpeciesBody weightAngiotensin converting enzyme (ACE)Blood biochemistryDiabetic kidney diseaseGlomerular filtration rate (GFR)EmpagliflozinHistopathology scoreImage analysisImmunohistochemistry (IHC)Kidney morphometryLight sheet fluorescence microscopy (LSFM)NephrectomySGLT-2LisinoprilSurgeryUrine biochemistry

Share this page

Resource Library

Related resources
Poster
Renal cell-type associated therapeutic effects of semaglutide in a mouse model of hypertension accelerated diabetic kidney disease
Poster
Renal cell-type associated therapeutic effects of semaglutide in a mouse model of hypertension accelerated diabetic kidney disease
Publication
Automated image analyses of glomerular hypertrophy in a mouse model of diabetic nephropathy
Poster
Cardiorenal protective effects of semaglutide in a mouse model of hypertension-accelerated diabetic kidney disease

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 ­2650

Back To Top